Gritstone Oncology, Inc. Contracts & Agreements

Senior Secured Super Priority Debtor-In-Possession Financing Agreement, dated as of November 13, 2024, by and among Gritstone bio, Inc., the lenders from time to time party... (Filed With SEC on November 15, 2024)

Second Amendment to Office Building Net Lease Agreement effective as of May 10, 2024 (Filed With SEC on August 13, 2024)

Underwriting Agreement, dated April 1, 2024 (Filed With SEC on April 2, 2024)

Form of Common Stock Warrant (Filed With SEC on April 2, 2024)

Form of Pre-Funded Warrant (Filed With SEC on April 2, 2024)

Amended and Restated Non-Employee Director Compensation Program (Filed With SEC on March 5, 2024)

Amendment No. 1 to Contract between the Company and the Biomedical Advanced Research and Development Authority, effective as of November 20, 2023 (Filed With SEC on March 5, 2024)

First Amendment to Office/Laboratory Lease, by and between Gritstone bio, Inc. and RREF II Kenmore Lessor III LLC and RREF II Kenmore Lessor IV LLC, effective as of September 20,... (Filed With SEC on March 5, 2024)

Contract between the Company and the Biomedical Advanced Research and Development Authority, dated September 27, 2023 (Filed With SEC on November 8, 2023)

Nonexclusive License and Development Agreement between the Company and Genevant Sciences GmbH, dated as of January 15, 2021 (Filed With SEC on November 8, 2023)

Amendment No.1 to Nonexclusive License and Development Agreement between the Company and Genevant Sciences GmbH, dated as of January 29, 2021 (Filed With SEC on November 8, 2023)

First Amendment to Loan and Security Agreement, dated as of March 31, 2023, by and among Gritstone bio Inc., as borrower, Silicon Valley Bank, a division of First-Citizens Bank &... (Filed With SEC on April 6, 2023)

Securities Purchase Agreement, dated October 24, 2022 (Filed With SEC on October 25, 2022)

Form of Pre-Funded Warrant (Filed With SEC on October 25, 2022)

Fourth Amendment to the License Agreement between Gritstone bio, Inc. and MIL 21E, LLC, effective as of June 30, 2022 (Filed With SEC on August 4, 2022)

Description of Common Stock (Filed With SEC on March 10, 2022)

Securities Purchase Agreement, dated September 16, 2021 (Filed With SEC on September 17, 2021)

Third Amendment to Research Collaboration and License Agreement, by and between Gritstone Oncology, Inc. and bluebird bio, Inc., effective February 18, 2021 (Filed With SEC on August 5, 2021)

Stockholder Agreement, dated January 29, 2021 (Filed With SEC on February 1, 2021)

Stock Purchase Agreement, dated January 29, 2021 (Filed With SEC on February 1, 2021)

Securities Purchase Agreement, dated December 28, 2020 (Filed With SEC on December 30, 2020)

Securities Purchase Agreement, dated December 22, 2020 (Filed With SEC on December 28, 2020)

Form of Pre-Funded Warrant (Filed With SEC on December 28, 2020)

Second Amendment to Research Collaboration and License Agreement, by and between Gritstone Oncology, Inc. and bluebird bio, Inc., effective August 19, 2020 (Filed With SEC on November 5, 2020)

Second Amendment to Office/Laboratory Lease, by and between Gritstone Oncology, Inc. and MIL 21E, LLC, effective as of May 20, 2020 (Filed With SEC on August 5, 2020)

Employment Agreement by and between Gritstone Oncology, Inc. and Rahsaan Thompson, effective as of March 2, 2020 (Filed With SEC on May 7, 2020)

Description of Common Stock (Filed With SEC on March 11, 2020)

First Amendment to Office/Laboratory Lease, by and between Gritstone Oncology, Inc. and MIL 21E, LLC, effective as of July 11, 2019 (Filed With SEC on November 12, 2019)

Office/Laboratory Lease, by and between Gritstone Oncology, Inc. and MIL 21E, LLC, effective as of September 6, 2018 (Filed With SEC on November 12, 2019)

Employment Agreement by and between Gritstone Oncology, Inc. and Vijay Yabannavar, Ph.D., effective as of July 2, 2019 (Filed With SEC on November 12, 2019)

Form of Underwriting Agreement (Filed With SEC on April 22, 2019)

Transition and Separation Agreement by and between Gritstone Oncology, Inc. and Jayant Aphale, Ph D., effective as of December 7, 2018 (Filed With SEC on March 28, 2019)

Lease Termination Agreement, by and between Gritstone Oncology, Inc. and Emery Station Joint Venture, LLC, effective as of January 28, 2019 (Filed With SEC on February 5, 2019)

Office/Laboratory Lease, by and between Gritstone Oncology, Inc. and Emery Station West, LLC, effective as of January 28, 2019 (Filed With SEC on February 5, 2019)

Employment Agreement by and between Gritstone Oncology, Inc. and Jean-Marc Bellemin (Filed With SEC on September 17, 2018)

Form of Underwriting Agreement (Filed With SEC on September 17, 2018)

Form of Common Stock Certificate (Filed With SEC on September 17, 2018)

2018 Incentive Award Plan (Filed With SEC on September 17, 2018)

Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Incentive Award Plan (Filed With SEC on September 17, 2018)

Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2018 Incentive Award Plan (Filed With SEC on September 17, 2018)

Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2018 Incentive Award Plan (Filed With SEC on September 17, 2018)

2018 Employee Stock Purchase Plan (Filed With SEC on September 17, 2018)

Employment Agreement by and between Gritstone Oncology, Inc. and Andrew Allen, M.D., Ph.D (Filed With SEC on September 17, 2018)

Employment Agreement by and between Gritstone Oncology, Inc. and Matthew Hawryluk, Ph.D (Filed With SEC on September 17, 2018)

Employment Agreement by and between Gritstone Oncology, Inc. and Karin Jooss, Ph.D (Filed With SEC on September 17, 2018)

Employment Agreement by and between Gritstone Oncology, Inc. and Raphal Rousseau, M.D., Ph.D (Filed With SEC on September 17, 2018)

Form of Indemnification Agreement (Filed With SEC on September 17, 2018)

Non-Employee Director Compensation Program (Filed With SEC on September 17, 2018)

Employment Agreement by and between Gritstone Oncology, Inc. and Erin Jones (Filed With SEC on September 17, 2018)

Employment Agreement by and between Gritstone Oncology, Inc. and Jayant Aphale, Ph.D (Filed With SEC on September 17, 2018)

Employment Agreement by and between Gritstone Oncology, Inc. and Roman Yelensky, Ph.D (Filed With SEC on September 17, 2018)

Form of Stock Option Agreement under 2015 Equity Incentive Plan (Filed With SEC on August 23, 2018)

Form of Early Exercise Stock Option Agreement under 2015 Equity Incentive Plan (Filed With SEC on August 23, 2018)

Form of Stock Purchase Right Grant Notice and Restricted Stock Purchase Agreement under 2015 Equity Incentive Plan (Filed With SEC on August 23, 2018)

2015 Equity Incentive Plan, as amended (Filed With SEC on August 23, 2018)

Office Building Net Lease, dated as of March 24, 2017, by and between Gritstone Oncology, Inc. and Hacienda Portfolio Venture, LLC (Filed With SEC on August 23, 2018)

Lease, dated as of February 11, 2016, by and between Gritstone Oncology, Inc. and BMR-Sidney Research Campus LLC (Filed With SEC on August 23, 2018)

Lease, dated as of November 11, 2015, by and between Gritstone Oncology, Inc. and Emery Station Joint Venture, LLC (Filed With SEC on August 23, 2018)

Amended and Restated Investors Rights Agreement dated as of June 29, 2018, by and among Gritstone Oncology, Inc. and the investors listed therein (Filed With SEC on August 23, 2018)

Amendment Number One to License Agreement, dated as of July 20, 2018, by and among Gritstone Oncology, Inc., Arbutus Biopharma Corporation and its subsidiary Protiva... (Filed With SEC on August 23, 2018)

License Agreement, dated as of October 16, 2017, by and among Gritstone Oncology, Inc., Arbutus Biopharma Corporation and its subsidiary Protiva Biotherapeutics Inc (Filed With SEC on August 23, 2018)

Category

Industry

Companies

Contracts

Gritstone Oncology, Inc. Contracts & Agreements